Day: June 9, 2025

EXEL IndustriesA French Société Anonyme with a share capital of €16,969,750Registered office: 54, rue Marcel Paul – 51206 Epernay Cedex – FranceReims Companies Register (RCS): No. 095 550 356 Number of shares and voting rightsArticle 223-16 of the AMF regulationDate Total number of shares comprising the share capital Total number of voting rightsMay 31, 2025   6,787,900   Theoretical voting rights: 9,891,627Exercisable voting rights*: 9,886,797* After deduction of shares without voting rightsAttachmentEXEL Industries Droits de vote 2025.05.31_EN

MONTREAL, June 09, 2025 (GLOBE NEWSWIRE) — PyroGenesis Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a high-tech company that designs, develops, manufactures and commercializes advanced all-electric plasma processes and sustainable solutions to support heavy industry in their energy transition, emission reduction, commodity security, and waste remediation efforts, announced today that up to 1,581,250 common share purchase warrants (the “Warrants”) will be amended. The Warrants, which have an exercise price of $1.20, will currently expire on July 22, 2025. Commencing on June 25, 2025, the expiration date of the Warrants held by holders wishing to participate in this proposal will be extended until November 18, 2025. The warrant certificates will also be amended to reflect the changes in PyroGenesis’ corporate...

One of the strategic goals indicated by AB Akola Group is normalised annual EBITDA range of EUR 70-90 million. Following the strong performance of the ongoing period, Group announces adjusted range for the implementation of this indicator in the financial year 2024/2025, changing from EUR 70-90 million to EUR 80-100 million.For more information: CFO of AB Akola Group Mažvydas ŠileikaMob. +370 619 19 403E-mail m.sileika@akolagroup.lt

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts are seeing a steep rise in popularity, growing from 4% of Total Knee Arthroplasty procedures in 2018 to 32% in 2023.1 With the ability to be used with or without the Posterior Cruciate Ligament (PCL), procedural trends are moving away from Posterior Stabilized (PS) design types to more bone-conservative Cruciate Retaining (CR) femoral designs. The reduction of operating steps also creates the potential for greater efficiency and shorter time in the OR for both surgeon and patient.2  The medial stabilized design aims to maintain stability with a larger anterior medial lip and medial pivot kinematics similar to the natural knee. “We’re...

shenzhen, June 09, 2025 (GLOBE NEWSWIRE) — MicroAlgo Inc. Integrates Quantum Image LSQb Algorithm with Quantum Encryption Technology to Build a More Secure Quantum Information Hiding and Transmission System Shenzhen, Jun. 09, 2025––MicroAlgo Inc. (the “Company” or “MicroAlgo”) (NASDAQ: MLGO), today announced that by integrating the quantum image LSQb algorithm with quantum encryption technology, they have proposed a brand-new information hiding and transmission scheme, aiming to build a more secure and efficient data protection mechanism.The LSQb algorithm, namely the Least Significant Quantum Bit algorithm for quantum images, is an innovative quantum image processing technology. It achieves secure information hiding by embedding secret information into the least significant quantum bits of a quantum image....

Leadership Transition Strengthens Board Oversight and Strategic Alignment Following Nasdaq ListingBrad Buswell, Chairman of the Board of Directors Brad Buswell, Chairman of the Board of Directors Brad Buswell, Chairman of the Board of Directors Atlanta, GA, June 09, 2025 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (the “Company” or “ScanTech AI”) (Nasdaq: STAI), a next-generation provider of AI-powered CT screening systems for aviation, customs, and critical infrastructure, today announced the appointment of Brad Buswell as Chairman of the Board of Directors, effective June 9, 2025. Mr. Buswell has served as a member of the Board of Directors since January 2025. “On behalf of the entire ScanTech AI team, I would like to thank Karl Brenza for his steady leadership and instrumental role in navigating...

MINNEAPOLIS, June 09, 2025 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced the pricing of a public offering of 406,755 shares of its common stock (“Common Stock”), pre-funded warrants to purchase 14,085,998 shares of Common Stock, in each case with accompanying Series A Warrants to purchase up to 43,478,259 shares of Common Stock and Series B Warrants to purchase up to 14,492,753 shares of Common Stock. The public offering price per share of Common Stock and accompanying warrants is $0.30 per share and accompanying warrants, and the public offering price per pre-funded warrant and accompanying warrants is $0.2999 per pre-funded warrant and accompanying warrants. Nuwellis expects to...

MIAMI, June 09, 2025 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that Wa’el Hashad, CEO, will present at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference, taking place June 16-17, 2025. Details for the Company’s corporate presentation:Pre-recorded presentation available on-demand Monday, June 16, at 7:00 a.m. ET Longeveron presentation webcast link: Click HereThe webcast for this conference presentation may be accessed at the “Events and Presentations” section of the Company’s website. A replay of the webcast will be available on the Longeveron website for 90 days following the conference. About Longeveron Inc.Longeveron is a clinical...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 09, 2025 (GLOBE NEWSWIRE) — Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) announces it is undertaking a rights offering to raise gross proceeds of up to approximately $5,336,592 (the “Rights Offering”) and concurrent offering under the listed issuer financing exemption to raise gross proceeds of up to approximately $3,200,000 (the “LIFE Offering”, and together with the Rights Offering, the “Offerings”), to bring the total amount raised by the Company to up to approximately $8,536,592. Directors and officers of the Company are expected to lead the financing and so long as room is available participate in one or both of the Offerings in a meaningful capacity. Rights...